A physiologically based pharmacokinetic analysis to predict the pharmacokinetics of intravenous isavuconazole in patients with or without hepatic impairment.

Huang, Huiping; Xie, Helin; Chaphekar, Nupur; Xu, Ruichao; Venkataramanan, Raman; Wu, Xuemei

Huang, Huiping; Xie, Helin; Chaphekar, Nupur; Xu, Ruichao; Venkataramanan, Raman; Wu, Xuemei.

Afiliação

Huang H; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Xie H; School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.
Chaphekar N; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Xu R; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.
Venkataramanan R; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.
Wu X; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.

Antimicrob Agents Chemother ; 65(5)2023 05 01.

Article em En | MEDLINE | ID: mdl-33619060

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google